{"disease":{"id":"malaria-vivax","name":"malaria vivax"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05052502","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":49118,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04416945","title":"Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":31443,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06923592","title":"Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":19200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT05096702","title":"Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":16000,"lead_sponsor_name":"Fundação de Medicina Tropical Dr. Heitor Vieira Dourado","has_results":false},{"nct_id":"NCT05540470","title":"Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield","phase":"NA","overall_status":"COMPLETED","enrollment_count":1991,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT06575647","title":"Vivax Elimination With Tafenoquine (VET) Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1242,"lead_sponsor_name":"Shoklo Malaria Research Unit","has_results":false},{"nct_id":"NCT06392152","title":"Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1208,"lead_sponsor_name":"Pyae Linn Aung","has_results":false},{"nct_id":"NCT04223674","title":"Serological Screen and Treat Trial for Plasmodium Vivax","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1133,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT04411836","title":"Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":960,"lead_sponsor_name":"Menzies School of Health Research","has_results":false},{"nct_id":"NCT05058885","title":"Plasmodium Vivax Among Duffy Negative Population in Cameroon.","phase":"","overall_status":"UNKNOWN","enrollment_count":900,"lead_sponsor_name":"University of Dschang","has_results":false},{"nct_id":"NCT01376167","title":"Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":851,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02001428","title":"Malaria in Early Life Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Gadjah Mada University","has_results":false},{"nct_id":"NCT05788094","title":"ACT vs CQ With Tafenoquine for P. Vivax Mono-infection","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":606,"lead_sponsor_name":"Shoklo Malaria Research Unit","has_results":false},{"nct_id":"NCT03916003","title":"Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Menzies School of Health Research","has_results":false},{"nct_id":"NCT02658435","title":"Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":486,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03208907","title":"DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":419,"lead_sponsor_name":"Fundação de Medicina Tropical Dr. Heitor Vieira Dourado","has_results":false},{"nct_id":"NCT06666491","title":"An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01928914","title":"Tafenoquine Thorough QTc Study in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03610399","title":"Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil","phase":"NA","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":true},{"nct_id":"NCT02216123","title":"Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05753150","title":"Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Dr. Prayuth Sudathip","has_results":false},{"nct_id":"NCT05361486","title":"Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Medicines for Malaria Venture","has_results":false},{"nct_id":"NCT07122232","title":"Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria","phase":"","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"Rafiullah Hotak","has_results":false},{"nct_id":"NCT03307369","title":"A Retrospective Study of Severe Plasmodium Vivax","phase":"","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04222088","title":"TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Research Institute for Tropical Medicine, Philippines","has_results":true},{"nct_id":"NCT02802501","title":"Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04739917","title":"Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Malaria Vaccine and Drug Development Center","has_results":false},{"nct_id":"NCT02184637","title":"A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07430592","title":"This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"R. Kiplin Guy","has_results":false},{"nct_id":"NCT06044805","title":"Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Dinka Dugassa","has_results":false},{"nct_id":"NCT05044637","title":"Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fundação de Medicina Tropical Dr. Heitor Vieira Dourado","has_results":false},{"nct_id":"NCT04228315","title":"Biomarkers of P. Vivax Relapse","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Armed Forces Research Institute of Medical Sciences, Thailand","has_results":false},{"nct_id":"NCT05958797","title":"TES of Chloroquine for Pv in the Philippines in 2016","phase":"","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Research Institute for Tropical Medicine, Philippines","has_results":false},{"nct_id":"NCT07373301","title":"Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Malaria Vaccine and Drug Development Center","has_results":false},{"nct_id":"NCT01290601","title":"Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":70,"lead_sponsor_name":"U.S. Army Medical Research and Development Command","has_results":true},{"nct_id":"NCT02563496","title":"A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03337152","title":"Assessing a Risk Model for G6PD Deficiency","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT06036030","title":"Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Syamsudin Abdillah,Ph.D, Pharm D","has_results":false},{"nct_id":"NCT02110784","title":"Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Alfasigma S.p.A.","has_results":false},{"nct_id":"NCT04079621","title":"Short Course Radical Cure of P. Vivax Malaria in Nepal","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Menzies School of Health Research","has_results":false},{"nct_id":"NCT05270265","title":"Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT04201431","title":"Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT04709692","title":"Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"R. Kiplin Guy","has_results":true},{"nct_id":"NCT03797989","title":"VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT04009096","title":"VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT03377296","title":"Study of Controlled Human Plasmodium Vivax Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05232227","title":"Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia","phase":"PHASE2, PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":47},"guidelines":[],"source":"Drug Landscape verified database"}